NL930056I2 - Imidazodiazepine-derivaten, werkwijze en tussenpr odukten voor de bereiding ervan, deze bevattende geneesmiddelen en de therapeutische toepassing ervan. - Google Patents

Imidazodiazepine-derivaten, werkwijze en tussenpr odukten voor de bereiding ervan, deze bevattende geneesmiddelen en de therapeutische toepassing ervan.

Info

Publication number
NL930056I2
NL930056I2 NL930056C NL930056C NL930056I2 NL 930056 I2 NL930056 I2 NL 930056I2 NL 930056 C NL930056 C NL 930056C NL 930056 C NL930056 C NL 930056C NL 930056 I2 NL930056 I2 NL 930056I2
Authority
NL
Netherlands
Prior art keywords
intermediates
preparation
therapeutic use
containing drugs
imidazodiazepine derivatives
Prior art date
Application number
NL930056C
Other languages
English (en)
Dutch (nl)
Other versions
NL930056I1 (nl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27509256&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL930056(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL930056I1 publication Critical patent/NL930056I1/nl
Publication of NL930056I2 publication Critical patent/NL930056I2/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/24—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in positions 2 and 4
    • C07D265/26—Two oxygen atoms, e.g. isatoic anhydride
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NL930056C 1979-10-04 1993-06-11 Imidazodiazepine-derivaten, werkwijze en tussenpr odukten voor de bereiding ervan, deze bevattende geneesmiddelen en de therapeutische toepassing ervan. NL930056I2 (nl)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CH897179 1979-10-04
CH897279 1979-10-04
CH1066479 1979-11-30
CH1066579 1979-11-30
CH571680 1980-07-25

Publications (2)

Publication Number Publication Date
NL930056I1 NL930056I1 (nl) 1993-09-01
NL930056I2 true NL930056I2 (nl) 1993-11-16

Family

ID=27509256

Family Applications (1)

Application Number Title Priority Date Filing Date
NL930056C NL930056I2 (nl) 1979-10-04 1993-06-11 Imidazodiazepine-derivaten, werkwijze en tussenpr odukten voor de bereiding ervan, deze bevattende geneesmiddelen en de therapeutische toepassing ervan.

Country Status (23)

Country Link
US (10) US4316839A (enExample)
EP (1) EP0027214B1 (enExample)
JP (1) JPH01156968A (enExample)
AR (1) AR227293A1 (enExample)
AU (1) AU533641B2 (enExample)
BR (1) BR8006404A (enExample)
CA (1) CA1143728A (enExample)
DE (1) DE3067868D1 (enExample)
DK (1) DK168094B1 (enExample)
FI (1) FI73683C (enExample)
GB (1) GB2060632B (enExample)
GR (1) GR70772B (enExample)
HU (1) HU182675B (enExample)
IE (1) IE50318B1 (enExample)
IL (1) IL61160A (enExample)
LU (1) LU88298I2 (enExample)
MC (1) MC1355A1 (enExample)
NL (1) NL930056I2 (enExample)
NO (1) NO155774C (enExample)
NZ (1) NZ195071A (enExample)
PH (1) PH16607A (enExample)
PT (1) PT71874B (enExample)
ZW (1) ZW21580A1 (enExample)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1143728A (en) * 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
CA1174673A (en) * 1981-02-27 1984-09-18 Walter Hunkeler Imidazodiazepines
US4352817A (en) * 1981-02-27 1982-10-05 Hoffmann-La Roche Inc. Imidazo-diazepines and their use
CA1184175A (en) * 1981-02-27 1985-03-19 Walter Hunkeler Imidazodiazepines
CA1185602A (en) * 1981-02-27 1985-04-16 Emilio Kyburz Imidazodiazepines
CA1173441A (en) * 1981-02-27 1984-08-28 Hoffmann-La Roche Limited Imidazodiazepines
MC1528A1 (fr) * 1982-07-21 1984-04-13 Hoffmann La Roche Imidazobenzodiazepines
DK151808C (da) * 1982-11-16 1988-06-20 Ferrosan As Analogifremgangsmaade til fremstilling af oxadiazolylimidazo-oe1,4aa-benzodiazepinderivater
US4723003A (en) * 1983-05-18 1988-02-02 Hoechst-Roussel Pharmaceuticals Inc. Benzopyrrolobenzodiazepines and quinobenzodiazepines
IL74070A (en) * 1984-01-19 1988-12-30 Hoffmann La Roche Imidazodiazepine derivatives,their manufacture and pharmaceutical compositions containing them
AU587802B2 (en) * 1985-03-08 1989-08-31 Ferrosan A/S Novel oxadiazolyl imidazobenzodiazepine derivatives and methods of preparing such compounds
US4745112A (en) * 1985-05-17 1988-05-17 A/S Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method III
US4622320A (en) * 1985-05-17 1986-11-11 As Ferrosan Oxadiazolylimidazobenzodiazepine, compositions, and method
DK174086D0 (da) * 1986-04-16 1986-04-16 Ferrosan As Nye benzodiazepinderivater samt fremgangsmaade til fremstilling af samme
FI880814A7 (fi) * 1987-03-10 1988-09-11 Hoffmann La Roche Imidazodiazepin-derivat.
GB8720414D0 (en) * 1987-08-28 1987-10-07 Roussel Lab Ltd Chemical compounds
CA1318668C (en) * 1988-08-05 1993-06-01 Heinz Carmann Radioiodine benzodiazepine derivatives
US5096695A (en) * 1988-08-05 1992-03-17 Hoffmann-Laroche Inc. Radioiodine benzodiazepines as brain imaging agents
CA1327572C (en) * 1988-08-31 1994-03-08 F. Hoffmann-La Roche Ag Imidazodiazepine derivatives
GB8909700D0 (en) * 1989-04-27 1989-06-14 Roussel Lab Ltd Chemical compounds
CA2015336A1 (en) * 1989-05-19 1990-11-19 F. Hoffmann-La Roche Ag Imidazodiazepines for the treatment of neurological symptoms
FR2660310B1 (fr) * 1990-03-27 1992-06-05 Adir Nouveaux derives de la 4h-pyrrolo[1,2a] thieno[2,3-f] diazepine[1,4], leur procede de preparation et les compositions pharmaceutiques les renfermant.
US5276028A (en) * 1990-06-22 1994-01-04 Nordisk A/S Imidazoquinoxaline compounds
US5371080A (en) * 1990-06-22 1994-12-06 Novo Nordisk A/S Imidazoquinazoline compounds and their use
TW201311B (enExample) * 1991-06-17 1993-03-01 Hoffmann La Roche
US5565449A (en) * 1991-10-18 1996-10-15 Genentech, Inc. Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
US5250679A (en) * 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
US5438035A (en) * 1994-06-24 1995-08-01 American Cyanamid Company Methods for controlling undesirable plant species with benzodiazepine compounds
TW349100B (en) * 1994-11-11 1999-01-01 Hoffmann La Roche Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines
US5670640A (en) * 1996-02-02 1997-09-23 Hoffmann-La Roche Inc. Process for the manufacture of imidazodiazepine derivatives
GB2328940B (en) * 1997-09-05 1999-12-08 Dong Kook Pharm Co Ltd A process for preparing benzodiazepine derivatives
PT1691811E (pt) 2003-12-11 2014-10-30 Sunovion Pharmaceuticals Inc Combinação de um sedativo e de um modulador de neurotransmissores e métodos para melhorar a qualidade do sono e tratamento da depressão
WO2006040038A1 (en) 2004-10-12 2006-04-20 F.Hoffmann-La Roche Ag Imidazo [1, 5-a]triazolo[1, 5-d]benzodiazepine derivatives for the treatment of cognitive disorders
CN101084220B (zh) 2004-10-20 2010-12-15 弗·哈夫曼-拉罗切有限公司 卤素取代的苯并二氮杂*衍生物
CA2584259C (en) 2004-10-20 2013-04-02 F. Hoffmann-La Roche Ag Imidazo-benzodiazepine derivatives
CA2590333C (en) 2004-12-14 2013-01-08 F. Hoffmann-La Roche Ag Tetracyclic imidazo-benzodiazepines as gaba receptors modulators
AU2006276998A1 (en) * 2005-05-16 2007-02-15 Wisys Technology Foundation, Inc. Gabaergic agents to treat memory deficits
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) * 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20070244143A1 (en) * 2006-03-08 2007-10-18 Braincells, Inc Modulation of neurogenesis by nootropic agents
US20100216734A1 (en) * 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2382975A3 (en) 2006-05-09 2012-02-29 Braincells, Inc. Neurogenesis by modulating angiotensin
JP2009536667A (ja) * 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド ５ｈｔ受容体介在性の神経新生
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
WO2008036678A2 (en) * 2006-09-19 2008-03-27 Braincells, Inc. Combination comprising a peroxisome proliferator activated receptor agent and a second neurogenic agent for treating a nervous system disorder, increasing neurodifferentiation and increasing neurogenesis
US20090054412A1 (en) * 2007-08-20 2009-02-26 John Alan Kemp Treatment of Sleep Disorders
WO2009024325A2 (en) 2007-08-20 2009-02-26 Evotec Neurosciences Gmbh Treatment of sleep disorders
US20090270373A1 (en) * 2008-04-11 2009-10-29 Cypress Biosciences, Inc. Treatment of down syndrom with benzodiazepine receptor antagonists
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
GB0917612D0 (en) * 2009-10-08 2009-11-25 Ge Healthcare Ltd In vivo imaging agents
CN103502224A (zh) 2011-02-23 2014-01-08 克鲁莱斯有限公司 氟马西尼络合物、包含该络合物的组合物及其用途
CN102267999B (zh) * 2011-07-15 2013-05-29 海南美兰史克制药有限公司 一种氟马西尼化合物及其制法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933794A (en) * 1971-08-04 1976-01-20 The Upjohn Company 2-(2-Alkynylamino)-3H-1,4-benzodiazepines
US4031079A (en) * 1975-09-22 1977-06-21 Mcneil Laboratories, Incorporated Intermediates for 2-aminobenzodiazepine-5-ones
US4002610A (en) * 1975-09-22 1977-01-11 Mcneil Laboratories, Incorporated 2-Aminobenzodiazepine-5-ones
US4118386A (en) * 1977-04-04 1978-10-03 Hoffmann-La Roche Inc. Synthesis of imidazo[1,5-a]diazepine-3-carboxylates
ZA806016B (en) * 1979-10-04 1981-09-30 Hoffmann La Roche Imidazodiazepine derivatives
CA1143728A (en) * 1979-10-04 1983-03-29 Max Gerecke Imidazodiazepine derivatives
JPH089074B2 (ja) * 1987-07-02 1996-01-31 株式会社アマダ タレツトパンチプレス

Also Published As

Publication number Publication date
NO155774B (no) 1987-02-16
LU88298I2 (fr) 1994-05-04
DK168094B1 (da) 1994-02-07
AR227293A1 (es) 1982-10-15
PT71874A (en) 1980-11-01
JPH0369913B2 (enExample) 1991-11-05
AU533641B2 (en) 1983-12-01
US4316839A (en) 1982-02-23
US4346033A (en) 1982-08-24
US4359420A (en) 1982-11-16
FI803135L (fi) 1981-04-05
DK391280A (da) 1981-04-05
NO802946L (no) 1981-04-06
NO155774C (no) 1987-05-27
US4346035A (en) 1982-08-24
DE3067868D1 (en) 1984-06-20
NZ195071A (en) 1984-08-24
PT71874B (en) 1982-03-31
US4346034A (en) 1982-08-24
IE802056L (en) 1981-04-04
JPH01156968A (ja) 1989-06-20
FI73683C (fi) 1987-11-09
EP0027214A1 (de) 1981-04-22
NL930056I1 (nl) 1993-09-01
EP0027214B1 (de) 1984-05-16
ZW21580A1 (en) 1981-04-29
FI73683B (fi) 1987-07-31
BR8006404A (pt) 1981-04-14
CA1143728A (en) 1983-03-29
PH16607A (en) 1983-11-24
US4363762A (en) 1982-12-14
HU182675B (en) 1984-02-28
AU6278280A (en) 1981-04-09
GR70772B (enExample) 1983-03-22
US4346032A (en) 1982-08-24
US4346030A (en) 1982-08-24
GB2060632A (en) 1981-05-07
IE50318B1 (en) 1986-04-02
MC1355A1 (fr) 1981-08-10
US4346031A (en) 1982-08-24
IL61160A (en) 1983-07-31
IL61160A0 (en) 1980-11-30
GB2060632B (en) 1983-11-02
US4346036A (en) 1982-08-24

Similar Documents

Publication Publication Date Title
NL930056I2 (nl) Imidazodiazepine-derivaten, werkwijze en tussenpr odukten voor de bereiding ervan, deze bevattende geneesmiddelen en de therapeutische toepassing ervan.
NL930110I2 (nl) Carbazolyl-(4)-oxypropanolamine-derivaten, werkwijze ter bereiding daarvan en geneesmiddelen, die deze verbindingen bevatten.
NL191738C (nl) ML-236B-derivaten, werkwijze voor hun bereiding en farmaceutische preparaten, die deze derivaten bevatten.
NL990027I2 (nl) Bisindoolverbindingen, farmaceutische preparaten die hen bevatten en werkwijze voor hun bereiding.
NL7804666A (nl) Weggooibare injectiespuit en werkwijze voor de vervaar- diging daarvan.
FI803849A7 (fi) Uudet asyylipeptidit, niistä valmistetut farmaseuttiset valmisteet, menetelmä niiden valmistamiseksi ja niiden käyttö.
FI812810A7 (fi) Ammoniometyyliyhdisteitä, menetelmiä niiden valmistamiseksi, näitä yhdisteitä sisältäviä farmaseuttisia valvalmisteita ja viimemainittujen käyttö.
NL192989B (nl) Antibioticum, werkwijze voor de bereiding en farmaceutisch preparaat dat dit antibioticum bevat.
NL7806380A (nl) Pyrazolyl-pyridazinederivaten, werkwijze voor de berei- ding hiervan alsmede de therapeutische toepassing.
DE3067830D1 (en) Trans-quinazoline derivatives, processes for their preparation, intermediates and medicaments containing these derivatives
NL184467C (nl) 6-oxo-prostaglandine eŸ1 derivaten, werkwijze voor de bereiding daarvan en farmaceutische preparaten, die deze bevatten.
NL7802069A (nl) Pyrrolidinederivaten, werkwijze voor de berei- ding daarvan en dergelijke pyrrolidinederivaten bevattende geneesmiddelen.
NL7803165A (nl) Nieuwe 7-aminothiazolylaceetamidocefalosporaan- zuuroximverbindingen, werkwijze voor hun berei- ding en farmaceutische preparaten.
NO147437C (no) Partikkelformig forstoff for droevtyggere.
NL187069C (nl) N-acyl 3-(1-amino-3-methylbutyl)-8-hydroxy-3,4-dihydro-isocoumarine verbinding, werkwijze voor de bereiding daarvan en farmaceutisch preparaat.
NL187397C (nl) Farmaceutische preparaten, 20,21-dinoreburnamenineverbindingen daarvoor en werkwijze voor hun bereiding.
NL7803896A (nl) Nieuwe pyrrolochinoxalineverbindingen, werkwijze voor hun bereiding en geneesmiddelen.
NL7811292A (nl) Pyridoxol-derivaat, werkwijze voor de bereiding daarvan en farmaceutische preparaten die het bevatten.
SE7812404L (sv) Substituerade pyrrolidiner, sett for framstellning och anvendning derav samt lekemedel, innehallande dessa pyrrolidiner
NL7802023A (nl) Nieuwe geneesmiddelcombinaties alsmede werkwijze voor de bereiding daarvan.
NL7810818A (nl) Nieuwe therapeutische toepassing van acetyl-1-carnitine en van derivaten van d,1-carnitine en 1-carnitine, alsmede het voor deze toepassing geschikte farmaceu- tische preparaat.
NL7705561A (nl) Farmaceutisch preparaat en werkwijzen voor de bereiding en toepassing ervan.
NL7714628A (nl) Gedisubstitueerde piperazinen, werkwijze voor de bereiding daarvan en dergelijke piperazinen bevattende geneesmiddelen.
NL7800097A (nl) Imidazool derivaten en werkwijzen voor de be- reiding en toepassing ervan.
NL7807572A (nl) Pyrazolylpyridazinederivaten, werkwijze voor de berei- ding hiervan en de toepassing als geneesmiddel.